Accessibility Skip to:
  • Accessibility Policy
  • Main Content
  • Main Menu
  • Contact

  • -A: Font Smaller
  • +A: Font Larger
  • Reset Font
  • High Contrast
  • Low Contrast
  • Reset Contrast
History:
You are here:
  • Grand Challenges Canada
  • >
  • Innovations
  • >
  • 0499-01-10
  • Français
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovation Marketplace
    • Innovations & Results
    • Annual Report
  • See Our Impact
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
Grand Challenges Canada

Bold Ideas with Big Impact®

Browse our Innovations and Results
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovation Marketplace
    • Innovations & Results
    • Annual Report
  • See Our Impact
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
  • Accessibility
  • Contact
  • Français

Home » Innovations » 0499-01-10

Skin Printer for Low Cost Wound Dressings and Skin Regeneration in Cambodia

FacebookTwitterLinked In

Start Date: 01/05/2014- End Date: 30/11/2015


Project Lead(s): Axel Guenther

Issue

Skin is the largest organ and forms a protective barrier against the external environment.

Following severe skin loss (>1sqm) as a result of burns, normal wound healing cannot reconstitute the barrier and multiple interventions are required for successful treatment.

The high cost and morbidity associated with current clinical procedures show the need for an innovative approach to developing skin substitutes.

Solution

This project aimed to further develop an approach for the scalable preparation of engineered skin substitutes.

A second-generation Skin Printer prototype was developed.

The Skin Printer is enabled by a microfluidic approach that converts cell-laden biopolymer solutions, upon interaction with cross-linking solutions, into cell-populated wound dressings that accurately reproduce the layered architecture of human skin.

The approach is based on a microfabricated printer cartridge that enables the scalable incorporation of skin microtissue regions within continuously produced hydrogel sheets.

Printed skin grafts consist of multiple viable cell types, have a precisely controlled graft thickness, structure (e.g., epidermis and dermis) and biomolecular composition that are characteristic of human skin.

The Gen I Skin Printer is scalable to produce skin grafts up to 10 folds wider than the smaller grafts, equivalent up to 60mm-wide sheets. In vivo validation of cell-populated bilayered skin grafts was performed on 6mm-diameter incision wounds in immune-incompetent mice.

Outcome

Results from the project demonstrated that the Skin Printer allows the rapid formation of engineered skin substitutes.

However, the Gen I Skin Printer was found to have two limitations: it requires the manual manipulation of printed skin substitutes to a wound bed, and the applied method of producing free-floating biomaterial sheets limits the range of compatible biomaterials.

To overcome both limitations, the project designed and manufactured two units of a Gen II Skin Printer – a handheld skin printer that deposits adhesive skin substitutes directly onto the wound skin, removing the need for any manipulation of skin substitutes.

The printing method is compatible with a much wider range of clinically approved biomaterials, including collagen I and fibrinogen.

The Gen II Skin Printer has been protected with a provisional U.S. patent.

The team has continued the characterization of the Gen II Skin Printer with a small Medicine by Design bridge-funded project.

The technology was not deployed to the Children's Surgical Centre in Cambodia, as originally planned, because of unforeseen challenges in accessing cell biology infrastructure in that country.

Future project plans involve the continuation of in vivo experiments in small (mice) and large (pig) animal wound models, as well as the modification of the microfluidic bioprinter to meet cGMP requirements for use in humans.

The team is currently addressing the scalability of the skin printer cartridges through three successive MITACS internship grants being conducted in collaboration with SMT Americas (Burlington, Ontario) and z-microsystems (Austria).

The team has not yet decided whether to apply to Transition To Scale (TTS) Phase II funding.

Image Gallery

  • 0499-01-10 Addressed Problem - SevereBurn
  • 0499-01-10 Illustration - PrintedSkinGraft
  • Print
  • 0499-01-10 SkinPrinter - Team

Stay in touch with this innovator

  • Organization Website
  • Network Website
  • Innovation Overview
    Program

    Stars in Global Health

    Institution

    University of Toronto

    Institution Country

    Canada

    Implementation Country

    Cambodia

    Implementation Region

    South Asia

    Priority

    Burns, Injuries

    Platform

    Medical Device

Grand Challenges Canada’s programs are primarily undertaken with the financial support of the Government of Canada provided through Global Affairs Canada.

Government of Canada
  • Fluxx Technical Support
  • Privacy Policy
  • Website Legal Terms and Disclaimer